Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01412944
What this trial is testing

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 43
Not applicableLooking for participantsNCT07039110
What this trial is testing

Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie 700
Large-scale testing (Phase 3)Study completedNCT06011733
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 133
Testing effectiveness (Phase 2)Study completedNCT01230138
What this trial is testing

Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH 252
Large-scale testing (Phase 3)Study completedNCT03255382
What this trial is testing

Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy

Who this might be right for
Psoriasis
AbbVie 120
Testing effectiveness (Phase 2)Study completedNCT00852670
What this trial is testing

ACT-128800 in Psoriasis

Who this might be right for
Plaque Psoriasis
Actelion 66
Testing effectiveness (Phase 2)Study completedNCT02899988
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 205
Large-scale testing (Phase 3)Active Not RecruitingNCT06630559
What this trial is testing

Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Celltrion 153
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Very early researchStudy completedNCT06555497
What this trial is testing

Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis

Who this might be right for
Pilot StudyPsoriasis
Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium 2
Large-scale testing (Phase 3)Study completedNCT02618759
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 119
Testing effectiveness (Phase 2)Study completedNCT00646191
What this trial is testing

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 137
Large-scale testing (Phase 3)Study completedNCT01815424
What this trial is testing

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 266
Testing effectiveness (Phase 2)Study completedNCT03000608
What this trial is testing

A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Santalis Pharmaceuticals, Inc. 69
Large-scale testing (Phase 3)Study completedNCT03701763
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 245
Large-scale testing (Phase 3)Active Not RecruitingNCT06611163
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

Who this might be right for
Moderate to Severe Genital Psoriasis
Sun Pharmaceutical Industries Limited 206
Testing effectiveness (Phase 2)WithdrawnNCT02993328
What this trial is testing

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults

Who this might be right for
Plaque Psoriasis
Santalis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT05600036
What this trial is testing

Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alumis Inc 228
Large-scale testing (Phase 3)Study completedNCT00237887
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 1,212
Testing effectiveness (Phase 2)Study completedNCT02969018
What this trial is testing

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Pfizer 212
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation